LivaNova (LIVN) Research & Development (2014 - 2026)
LivaNova's (LIVN) quarterly Research & Development came in at $53.7 million in Q2 2026, up 13.73% year-over-year from $47.2 million in Q2 2025, and down 8.57% quarter-over-quarter from $58.7 million in Q1 2026.
Analysis
LivaNova (LIVN) Research & Development (2014 - 2026) Analysis & Trends
LivaNova has disclosed Research & Development across 13 years of filings, most recently posting $53.7 million for Q2 2026.
- In Q2 2026, Research & Development rose 13.73% year-over-year to $53.7 million; the TTM figure through Jun 2026 stood at $213.1 million (up 20.25% YoY), while the FY2025 annual figure was $185.8 million, up 1.78% from the prior year.
- Research & Development came in at $53.7 million for Q2 2026 at LivaNova, down from $58.7 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $58.7 million in Q1 2026 to a low of $34.2 million in Q2 2022.
- Average Research & Development over 5 years is $46.1 million, with a median of $46.4 million recorded in 2023.
- Year-over-year, Research & Development sank 34.87% in 2022 and soared 54.95% in 2026.
- Over 5 years, Research & Development stood at $44.9 million in 2022, then increased by 2.74% to $46.2 million in 2023, then declined by 6.19% to $43.3 million in 2024, then increased by 20.35% to $52.1 million in 2025, then climbed by 2.95% to $53.7 million in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $53.7 million in Q2 2026, $58.7 million in Q1 2026, and $52.1 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 771.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 434.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 554.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 278.90 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -663.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 153.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 28.60 Mn |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn | 53.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53.66 Mn |
| Mar 31, 2026 | 58.70 Mn |
| Dec 31, 2025 | 52.12 Mn |
| Sep 30, 2025 | 48.58 Mn |
| Jun 30, 2025 | 47.19 Mn |
| Mar 31, 2025 | 37.88 Mn |
| Dec 31, 2024 | 43.31 Mn |
| Sep 30, 2024 | 48.81 Mn |
| Jun 30, 2024 | 44.74 Mn |
| Mar 31, 2024 | 45.66 Mn |
| Dec 31, 2023 | 46.17 Mn |
| Sep 30, 2023 | 46.54 Mn |
| Jun 30, 2023 | 51.12 Mn |
| Mar 31, 2023 | 49.99 Mn |
| Dec 31, 2022 | 44.93 Mn |
| Sep 30, 2022 | 35.73 Mn |
| Jun 30, 2022 | 34.23 Mn |
| Mar 31, 2022 | 40.92 Mn |
| Dec 31, 2021 | 44.10 Mn |
| Sep 30, 2021 | 42.13 Mn |